JP2904628B2 - Fair skin - Google Patents

Fair skin

Info

Publication number
JP2904628B2
JP2904628B2 JP3354594A JP35459491A JP2904628B2 JP 2904628 B2 JP2904628 B2 JP 2904628B2 JP 3354594 A JP3354594 A JP 3354594A JP 35459491 A JP35459491 A JP 35459491A JP 2904628 B2 JP2904628 B2 JP 2904628B2
Authority
JP
Japan
Prior art keywords
extract
manita
cells
whitening
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP3354594A
Other languages
Japanese (ja)
Other versions
JPH05170638A (en
Inventor
正紀 宇田
雅之 岩田
了二 小平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOWA KOGYO KK
Original Assignee
DOWA KOGYO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DOWA KOGYO KK filed Critical DOWA KOGYO KK
Priority to JP3354594A priority Critical patent/JP2904628B2/en
Publication of JPH05170638A publication Critical patent/JPH05170638A/en
Priority to FR9314195A priority patent/FR2712806B1/en
Application granted granted Critical
Publication of JP2904628B2 publication Critical patent/JP2904628B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、皮膚美白効果を有する
色白化粧料に関し、さらに詳しくは、メラニン生成抑制
作用に基づく美白効果を有する植物抽出物を有効成分と
して配合した色白化粧料に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a whitening cosmetic having a skin whitening effect, and more particularly to a whitening cosmetic in which a plant extract having a whitening effect based on a melanin production inhibitory action is blended as an active ingredient.

【0002】[0002]

【従来の技術】日焼けによる色黒、シミ、ソバカス等
は、黒褐色無定形の色素であるメラニンの生成により生
じるものと考えられており、このメラニンは、皮膚が紫
外線などの外的刺激を受けると、皮膚のメラニン細胞中
に存在するチロシナーゼ(チロシン酸化酵素)が活性化
し、たんぱく質構成アミノ酸の一種であるチロシンが酸
化されて生成する。したがって、メラニン生成に関与す
るチロシナーゼの活性を抑制することにより肌を白くす
る効果が期待されるため、チロシナーゼ活性抑制成分の
化粧料への配合が提唱されていた。
2. Description of the Related Art It is considered that darkening, spots, freckles, and the like due to sunburn are caused by the production of melanin, a black-brown amorphous pigment, and this melanin is exposed to external stimuli such as ultraviolet rays. Tyrosinase (tyrosine oxidase) present in melanocytes of the skin is activated, and tyrosine, one of the amino acids constituting protein, is oxidized and produced. Therefore, since an effect of whitening skin is expected by suppressing the activity of tyrosinase involved in melanin production, it has been proposed to add a tyrosinase activity inhibitory component to cosmetics.

【0003】従来、美白効果を有する色白化粧料とし
て、特公昭55−43443号「美白化粧料」や特公昭
54−974号「生薬抽出物配合組成物」に開示される
ように、アスコルビン酸またはその誘導体を配合したも
のが知られている。他にも、アルブチンを配合した皮膚
外用剤(特開昭60−16906号等)やコウジ酸を配
合した漂白化粧料(特公昭32−8100号)、植物成
分(特開昭63−2913号他)または動物成分(特開
昭63−8312号他)から抽出した化粧料が美白効果
を有するものとして公知である。
[0003] Conventionally, as whitening cosmetics having a whitening effect, as disclosed in JP-B-55-43443, "Whitening cosmetics" and JP-B-54-974, "Composition of crude drug extract", ascorbic acid or What blended the derivative is known. In addition, skin external preparations containing arbutin (JP-A-60-16906), bleaching cosmetics containing kojic acid (Japanese Patent Publication No. 32-8100), plant components (JP-A-63-2913, etc.) ) Or animal components (JP-A-63-8312, etc.) are known as having a whitening effect.

【0004】しかしながら、上記従来の化粧料は、充分
な美白効果が認められないものが多く、また、保存安定
性が充分でなかったり、刺激性を有するなど皮膚に対す
る安全性に問題があるものも多かった。
[0004] However, many of the above-mentioned conventional cosmetics do not show a sufficient whitening effect, and some of them have problems in safety to the skin such as insufficient storage stability and irritation. There were many.

【0005】[0005]

【発明が解決しようとする課題】本発明は、上述従来の
技術の問題点を解決し、優れた皮膚美白効果を有し、か
つ充分な保存安定性および高い安全性を有する色白化粧
料を提供することを目的とする。
SUMMARY OF THE INVENTION The present invention solves the above-mentioned problems of the prior art and provides a fair-skin cosmetic having an excellent skin whitening effect, sufficient storage stability and high safety. The purpose is to do.

【0006】[0006]

【課題を解決するための手段】本発明者等は斯る課題を
解決するために鋭意研究した結果、フローロ・デ・マニ
ータ(Flor de Manita)の抽出物がチロシナーゼ酵素活
性阻害作用、およびメラノーマ細胞におけるメラニン生
成抑制作用を有することを見い出し、本発明を提供する
ことができた。
Means for Solving the Problems The present inventors have made intensive studies to solve the above problems, and as a result, the extract of Floro de Manita showed an inhibitory effect on tyrosinase enzyme activity and melanoma cells. The present invention was found to have a melanin production inhibitory effect, and could provide the present invention.

【0007】すなわち本発明は、メキシコ原産の植物で
あるフローロ・デ・マニータ(Florde Manita)の抽出
物を配合したことを特徴とする色白化粧料を提供するも
のである。
That is, the present invention provides a fair-skin cosmetic characterized by containing an extract of Floro de Manita, a plant native to Mexico.

【0008】[0008]

【作用】本発明の化粧料は、次に示すような方法で製造
することができる。まず、メキシコ原産の植物の1種で
あるフローロ・デ・マニータ(Flor de Manita)[別名
MACPALXOCHITLとも言う]の乾燥物あるいは乾燥物粉砕
物を、抽出溶媒を用いて加熱抽出する。なお、該抽出溶
媒としては、アルコール(メタノール、エタノール、プ
ロパノールまたはイソプロピルアルコール等)や水など
を用いることができ、また、これらの混合溶液を用いる
こともできる。例えば、アルコール濃度が20〜70%の含
水アルコールを用い、50℃で1時間の抽出を行うと抽出
効率が良い。
The cosmetic of the present invention can be manufactured by the following method. First, Flor de Manita, a kind of plant native to Mexico [also known as Flor de Manita]
MACPALXOCHITL], or a dry ground product is extracted by heating using an extraction solvent. In addition, as the extraction solvent, alcohol (methanol, ethanol, propanol, isopropyl alcohol, or the like), water, or the like can be used, and a mixed solution thereof can also be used. For example, extraction efficiency is good when extraction is performed at 50 ° C. for 1 hour using hydroalcohol having an alcohol concentration of 20 to 70%.

【0009】抽出後、抽出液を濾別して抽出エキスを得
る。得られた抽出エキスは、さらに60℃以下の温度で加
熱しながら減圧濃縮して乾固させ、乾固した抽出物を回
収して化粧料に配合する。なお、上記抽出エキスをその
まま化粧料に配合しても良い。
After extraction, the extract is filtered to obtain an extract. The obtained extract is further concentrated under reduced pressure while heating at a temperature of 60 ° C. or lower to dryness, and the dried extract is collected and blended into cosmetics. In addition, you may mix the said extract with cosmetics as it is.

【0010】このようにして得たフローロ・デ・マニー
タの抽出物は、従来より用いられてきたアスコルビン酸
と比較して、低濃度で優れたメラニン生成抑制作用を発
揮することが本発明者等によって確認されており、この
抽出物を有効成分として0.01〜5.0 %配合することによ
り、美白効果を有する色白化粧料を得ることができる。
[0010] The present inventors have found that the extract of Floro de Manita thus obtained exhibits an excellent inhibitory action on melanin production at a low concentration as compared with conventionally used ascorbic acid. By adding this extract as an active ingredient in an amount of 0.01 to 5.0%, a whitening cosmetic having a whitening effect can be obtained.

【0011】以下、実施例により本発明をさらに詳細に
説明する。しかし本発明の範囲は以下の実施例により制
限されるものではない。
Hereinafter, the present invention will be described in more detail with reference to examples. However, the scope of the present invention is not limited by the following examples.

【0012】[0012]

【実施例1】本実施例では、フローロ・デ・マニータの
抽出方法の一例を示す。まず、メキシコ原産の植物の1
種であるフローロ・デ・マニータ(Flor de Manita)
[別名MACPALXOCHITLとも言う]の乾燥物約 100gをミ
キサーで粉砕し、その粉砕物および1リットルの50%エ
チルアルコールをフラスコに入れ、撹拌しながら50℃で
1時間環流抽出を行った。抽出後、この溶液を吸引濾過
し、得られた濾液をエバポレーターを用いて50℃にて減
圧濃縮した。次いで得られた濃縮液を減圧乾燥し、10g
の褐色結晶体(抽出物)を得た。
Embodiment 1 In this embodiment, an example of a method for extracting Floro de Manita will be described. First, one of the plants native to Mexico
Flor de Manita is a seed
About 100 g of the dried product of [also called MACPALXOCHITL] was pulverized with a mixer, and the pulverized product and 1 liter of 50% ethyl alcohol were placed in a flask and refluxed at 50 ° C. for 1 hour with stirring. After the extraction, this solution was subjected to suction filtration, and the obtained filtrate was concentrated under reduced pressure at 50 ° C. using an evaporator. Then, the obtained concentrated liquid was dried under reduced pressure, and 10 g
A brown crystal (extract) was obtained.

【0013】[0013]

【実施例2】本実施例では、実施例1で得たフローロ・
デ・マニータの抽出物のチロシナーゼ活性阻害作用の測
定を行った。なお、チロシナーゼ活性阻害作用の測定
は、ドーパからチロシナーゼにより生産されるドーパク
ロムを、 475nmの吸光度測定によって定量する方法を用
いた。また、チロシナーゼ活性阻害作用の測定にあたっ
ては、次のような反応試薬を用いた。 (イ)コハク酸ナトリウムバッファー(100 mM、pH 5.
5) (ロ)マッシュルームチロシナーゼ(SIGMA 社製)溶液
(270 units/mlに(イ)のバッファーで調整) (ハ)L-DOPA(和光純薬工業製)溶液(6mM に(イ)の
バッファーで調整)
[Embodiment 2] In this embodiment, the flowmeter obtained in Embodiment 1 is used.
The tyrosinase activity inhibitory effect of the extract of De Manita was measured. The tyrosinase activity inhibitory effect was measured by a method of quantifying dopachrome produced from dopa by tyrosinase by measuring absorbance at 475 nm. In measuring the tyrosinase activity inhibitory action, the following reaction reagents were used. (A) Sodium succinate buffer (100 mM, pH 5.
5) (b) Mushroom tyrosinase (SIGMA) solution (adjusted to 270 units / ml with (a) buffer) (c) L-DOPA (Wako Pure Chemical Industries) solution (6 mM to (b) buffer) Adjustment)

【0014】まず、試験管に(イ)のバッファー1.8ml
および(ロ)のチロシナーゼ溶液0.1ml を入れ、この試
験管にそれぞれ 2%(w/v) 、 1%(w/v) または 0.5%(w
/v)の各濃度の試料溶液(実施例1で得た抽出物の水溶
液)0.1ml を加え、30℃の恒温水層で15分間インキュベ
ートした。次いで、この試験管に(ハ)のL-DOPA溶液を
1ml 加え、撹拌した後、30℃の恒温室中で往復振とう機
に該試験管を約45°傾けてセットし、40分間振とう(往
復回数150/分)した。振とう後、分光光度計を用いて 4
75nmの吸光度を測定し、その測定値をAとした。
First, 1.8 ml of the buffer (a) was placed in a test tube.
0.1 ml of the tyrosinase solution of (b) and (2) were added to the test tubes, respectively, at 2% (w / v), 1% (w / v) or 0.5% (w).
(v) 0.1 ml of a sample solution (an aqueous solution of the extract obtained in Example 1) of each concentration was added, and the mixture was incubated for 15 minutes in a thermostatic water layer at 30 ° C. Next, the L-DOPA solution of (c) was added to this test tube.
After adding 1 ml and stirring, the test tube was set at about 45 ° in a reciprocating shaker in a thermostatic chamber at 30 ° C., and shaken for 40 minutes (reciprocation frequency 150 / min). After shaking, use a spectrophotometer for 4
The absorbance at 75 nm was measured, and the measured value was designated as A.

【0015】一方、コントロールとして試料溶液の代わ
りに(イ)のバッファーを加えたこと以外は上記と同様
にして 475nmの吸光度を測定し、その測定値をBとし、
また、ブランクとしてL-DOPA溶液の代わりに(イ)のバ
ッファーを加えたこと以外は上記と同様にして 475nmの
吸光度を測定し、その測定値をCとした。
On the other hand, the absorbance at 475 nm was measured in the same manner as above except that the buffer (a) was added instead of the sample solution as a control.
Further, the absorbance at 475 nm was measured in the same manner as above except that the buffer (a) was added instead of the L-DOPA solution as a blank.

【0016】上記 475nmの吸光度の測定値から試料溶液
のチロシナーゼ活性阻害率を算出した。なお、チロシナ
ーゼ活性阻害率の算出は、以下の計算式を用いて行い、
その結果を表1に示した。 チロシナーゼ活性阻害率(%)={1−(A−C)/
B}×100
The tyrosinase activity inhibition rate of the sample solution was calculated from the measured value of the absorbance at 475 nm. The calculation of the tyrosinase activity inhibition rate is performed using the following formula,
The results are shown in Table 1. Tyrosinase activity inhibition rate (%) = {1- (AC) /
B} × 100

【表1】 [Table 1]

【0017】表1からもわかるように、フローロ・デ・
マニータの抽出物は 0.5%水溶液という低濃度のもので
あっても、チロシナーゼの活性を59%も阻害しており、
極めて優れたチロシナーゼ活性阻害作用を有することが
確認された。
As can be seen from Table 1, Floro de.
Manita extract, even at a low concentration of 0.5% aqueous solution, inhibits tyrosinase activity by as much as 59%.
It was confirmed to have an extremely excellent tyrosinase activity inhibitory action.

【0018】[0018]

【実施例3】本実施例では、実施例1で得たフローロ・
デ・マニータの抽出物のメラニン生成抑制作用の測定を
行った。
[Embodiment 3] In this embodiment, the flow meter obtained in Embodiment 1 is used.
The melanin production inhibitory effect of the de Manita extract was measured.

【0019】まず、メラニンを生成するマウス由来の悪
性黒色種細胞であるB16メラノーマ細胞(B16-F0、ATCC
No. CRL-6322 )を、ウシ胎児血清で終濃度10%となる
ように添加したイーグルMEM培地で培養し、6ウェル
プレート(FALCON社製)の各ウェルに、該細胞を 3×10
3 cell/ml の濃度で含む上記培地を 6ml入れ、CO2
ンキュベーター(5%CO2 、37℃)内で5日間培養し
た。
First, B16 melanoma cells (B16-F0, ATCC), which are malignant melanoma cells derived from mice that produce melanin
No. CRL-6322) was cultured in Eagle's MEM medium supplemented with fetal bovine serum to a final concentration of 10%, and the cells were added to each well of a 6-well plate (FALCON) at 3 × 10 5.
6 ml of the above medium containing 3 cells / ml was added and cultured in a CO 2 incubator (5% CO 2 , 37 ° C.) for 5 days.

【0020】次いで、この培地を0.03%のテオフィリン
(SIGMA社製)を含む新しいイーグルMEM培地(6 ml)
に交換し、各ウェルに適当な量の試料溶液(実施例1で
得た抽出物の水溶液)を添加した後さらに3日間培養し
た。培養終了後、該培養液から培地を捨てて各ウェルに
1mlの生理食塩水を加え、スクレーパーを用いてウェル
の底面に付着している細胞をかきとるように懸濁させ
た。次に、ピペットを用いて該細胞懸濁液をマイクロ遠
心チューブ(1.5ml容量、エッペンドルフ社製)に移し、
遠心分離(1,000 ×g、15分間)した。
Next, the medium was added with 0.03% theophylline.
New Eagle MEM medium (6 ml) containing (SIGMA)
After adding an appropriate amount of a sample solution (aqueous solution of the extract obtained in Example 1) to each well, the cells were further cultured for 3 days. After completion of the culture, the medium was discarded from the culture solution, 1 ml of physiological saline was added to each well, and the cells adhered to the bottom of the well were suspended using a scraper to scrape the cells. Next, the cell suspension was transferred to a microcentrifuge tube (1.5 ml volume, manufactured by Eppendorf) using a pipette.
Centrifugation (1,000 xg, 15 minutes).

【0021】一方、対照として試料溶液の代わりに滅菌
水を添加して上記同様の試験を行った。また、細胞の白
色化を比較するための実験区として、試料溶液の代わり
に 2%L−アスコルビン酸水溶液を (a)60μl、(b)150
μl、(c)300μl添加し、上記同様の試験を行った。
On the other hand, as a control, the same test as described above was conducted by adding sterilized water instead of the sample solution. In addition, as an experimental group for comparing the whitening of the cells, a 2% L-ascorbic acid aqueous solution was used instead of the sample solution (a) 60 μl, (b) 150 μl.
μl and (c) 300 μl were added, and the same test was performed.

【0022】次に、ペレットとなった細胞の白色化の度
合を目視で比較し、メラニン生成抑制効果の判定を行っ
た。その際、対照実験区(滅菌水添加区)の細胞の白色
の度合を「−」、L−アスコルビン酸を添加した比較実
験区の細胞の白色の度合をそれぞれ (a):「+」、(b)
:「++」、 (c):「+++」として、試料溶液を添
加した場合の細胞の白色の度合が−、+、++、+++
のどれに対応するかを目視で判断し、試料溶液のメラニ
ン生成抑制効果の強さとして4段階の判定を行った。な
お、その結果は表2に示した。
Next, the degree of whitening of the pelleted cells was visually compared to determine the melanin production inhibitory effect. At that time, the degree of whiteness of the cells in the control experiment (sterilized water-added) was "-", and the degree of whiteness of the cells in the comparative experiment to which L-ascorbic acid was added was (a): "+", ( b)
: “++”, (c): As “++++”, the degree of whiteness of the cells when the sample solution was added was −, +, ++, +++
It was visually determined which one of the two corresponded, and the strength of the melanin production inhibitory effect of the sample solution was determined in four steps. The results are shown in Table 2.

【表2】 [Table 2]

【0023】表2からもわかるように、フローロ・デ・
マニータの抽出物は 200μg/mlの濃度でL−アスコルビ
ン酸 500μg/mlと同等のメラニン生成抑制作用を示し、
L−アスコルビン酸よりはるかに低濃度でメラニン生成
を抑制することが確認された。また、1,000 μg/mlの高
濃度のものであっても細胞に対する毒性はなかった。
As can be seen from Table 2, Floro de.
At a concentration of 200 μg / ml, the extract of Manita showed an inhibitory effect on melanin production equivalent to 500 μg / ml of L-ascorbic acid,
It was confirmed that melanin production was suppressed at a much lower concentration than L-ascorbic acid. Even at a high concentration of 1,000 μg / ml, there was no toxicity to cells.

【0024】[0024]

【実施例4】本実施例では、実施例1で得たフローロ・
デ・マニータの抽出物の色白化粧料への配合例を示す。 (重量%) フローロ・デ・マニータ抽出物 1.0 グリセリン 5.0 ポリオキシエチレンソルビタンモノラウレート 1.5 エタノール 10.0 香料 適量 防腐剤、酸化防止剤 適量 色素 適量 精製水 残部
[Embodiment 4] In this embodiment, the flowmeter obtained in Embodiment 1 is used.
An example of blending the extract of De Manita into a fair skin cosmetic is shown. (Wt%) Floro de Manita extract 1.0 Glycerin 5.0 Polyoxyethylene sorbitan monolaurate 1.5 Ethanol 10.0 Perfume Appropriate Preservative, antioxidant Appropriate pigment Appropriate amount Purified water Remainder

【0025】[0025]

【発明の効果】メキシコ原産の植物であるフローロ・デ
・マニータの抽出物は、優れたチロシナーゼ活性阻害作
用を有しており、この抽出物を配合した色白化粧料は優
れた皮膚美白効果を発揮する。また、フローロ・デ・マ
ニータの抽出物は、少量で優れた皮膚美白効果を発揮
し、細胞への毒性も低いため、安全性の高いものであ
る。
The extract of Floro de Manita, a plant native to Mexico, has an excellent inhibitory effect on tyrosinase activity, and a fair skin cosmetic containing this extract exhibits an excellent skin whitening effect. I do. In addition, the extract of Floro de Manita exhibits excellent skin whitening effect in a small amount and has low toxicity to cells, so that it is highly safe.

───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.6,DB名) A61K 7/00 - 7/50 A61K 35/78 WPI(DIALOG)────────────────────────────────────────────────── ─── Continued on the front page (58) Fields surveyed (Int. Cl. 6 , DB name) A61K 7/00-7/50 A61K 35/78 WPI (DIALOG)

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 メキシコ原産の植物であるフローロ・デ
・マニータ(Flor deManita)の抽出物を配合したことを
特徴とする色白化粧料。
1. A fair-skin cosmetic containing an extract of Flor de Manita, a plant native to Mexico.
JP3354594A 1991-12-19 1991-12-19 Fair skin Expired - Fee Related JP2904628B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP3354594A JP2904628B2 (en) 1991-12-19 1991-12-19 Fair skin
FR9314195A FR2712806B1 (en) 1991-12-19 1993-11-26 Cosmetic preparation for lightening the skin.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3354594A JP2904628B2 (en) 1991-12-19 1991-12-19 Fair skin
FR9314195A FR2712806B1 (en) 1991-12-19 1993-11-26 Cosmetic preparation for lightening the skin.

Publications (2)

Publication Number Publication Date
JPH05170638A JPH05170638A (en) 1993-07-09
JP2904628B2 true JP2904628B2 (en) 1999-06-14

Family

ID=26230764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3354594A Expired - Fee Related JP2904628B2 (en) 1991-12-19 1991-12-19 Fair skin

Country Status (2)

Country Link
JP (1) JP2904628B2 (en)
FR (1) FR2712806B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58131911A (en) * 1983-01-27 1983-08-06 Sansho Seiyaku Kk Cosmetic for fair-complexioned face containing fatty acid ester of quercetin
IL99291A (en) * 1991-08-23 1997-04-15 Fischer Pharma Ltd Cosmetic preparations

Also Published As

Publication number Publication date
FR2712806A1 (en) 1995-06-02
JPH05170638A (en) 1993-07-09
FR2712806B1 (en) 1996-11-08

Similar Documents

Publication Publication Date Title
JPH07277944A (en) Melanism inhibitor
US20060216253A1 (en) Whitening cosmetics containing morus alba extracts
JP3502415B2 (en) Maillard reaction inhibitor
JP2952636B2 (en) Melanin production inhibitor, method for producing the same, and whitening cosmetic containing the same
KR102063686B1 (en) Skin external composition containing extract of soybean root
JP2749218B2 (en) Cosmetic composition for whitening
JPH11147834A (en) Serine protease inhibitor
JP3236347B2 (en) Whitening cosmetics
JP3195047B2 (en) Whitening cosmetics
JP3231908B2 (en) Whitening cosmetics
JP3466243B2 (en) Whitening cosmetics
JP3449759B2 (en) Whitening cosmetics
JP2904628B2 (en) Fair skin
JPH04282321A (en) Cosmetic
JP3231898B2 (en) Whitening cosmetics
JPH06219934A (en) Skin-whitening cosmetic
JP2002068958A (en) Skin-whitening cosmetic
JP3231907B2 (en) Whitening cosmetics
JPH07126148A (en) Cosmetic
JP2002029923A (en) Collagen production promoter, elastase activity inhibitor, collagen activity inhibitor and skin cosmetic
JPH07233044A (en) Cosmetic for preventing aging
JP2000007546A (en) Pigmentation preventing agent and skin cosmetic and skin lotion produced by using the agent
KR102244710B1 (en) Use of Gel Comprising Plant As Raw Material
JP2001181170A (en) Skin care preparation
JPH11147833A (en) Collagenase inhibitor

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080326

Year of fee payment: 9

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080326

Year of fee payment: 9

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080326

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090326

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090326

Year of fee payment: 10

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100326

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100326

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110326

Year of fee payment: 12

LAPS Cancellation because of no payment of annual fees